abstract |
Polypeptides and related antibodies comprising variant Fc domains are described herein. The variant Fc domain provides a stable Fc:Fc interaction upon binding of said polypeptide, antibody or antibodies, to its target, antigen or antigens on the cell surface, thus providing improved complement dependent cytotoxicity (CDC). |